Skip to main content

Table 1 summary of the response criteria used in the study

From: RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study

 

RECIST 1.1

RECIST 10%

CHOI

mCHOI

Measurement

largest Diameter

largest diameter

largest diameter + attenuationa

largest diameter +

attenuationa

Responders

Decrease ≥30% of the sum of LD of TL or complete response

Decrease >10% of the sum of LD of TL or complete response

Decrease ≥10% of the sum of LD of TL or ≥ 15% of the mean attenuation of TL

Decrease ≥10% of the sum of LD of TL and ≥ 15% of the mean attenuation of TL

Non responders

Do not meet the responder criteria

  1. aattenuation in Hounsfield units assessed in a free-hand region of interest drawn about 1 mm inside the lesion boundaries on the CECT section whose largest diameter had been measured
  2. LD largest diameter, TL Target lesions, CECT Contrast enhanced computed tomography